A 62-year-old woman presented with a markedly increased serum ALP level of skeletal origin during a regular follow-up of chronic hepatitis C. Serum calcium, phosphorus, and intact-PTH levels were normal and bone turnover markers were increased. Her generalized bone density was diffusely increased. These findings were consistent with hepatitis C-associated osteosclerosis (HCAO). She underwent cholecystectomy, as gallbladder cancer was suspected; however, histopathological findings demonstrated xanthogranulomatous cholecystitis. After cholecystectomy, serum ALP level and bone turnover markers were gradually decreased. This may indicate the existence of a novel osteogenic factor in the gallbladder in HCAO.
Introduction
Hepatitis C virus (HCV) infects approximately 170 million people and is a leading cause of chronic liver disease worldwide (1). It is not only a frequent cause of chronic liver diseases, such as hepatitis, cirrhosis and hepatocellular carcinoma, but it is also involved in the pathogenesis of extra-hepatic diseases, such as arthritis, vasculitis, sicca syndrome, porphyria cutanea tarda, lichen planus, nephropathies, thyroid diseases, and lung fibrosis (2) . Hepatitis Cassociated osteosclerosis (HCAO) is a rare disorder characterized by a generalized increase in bone mass in adults who are infected with HCV (3). Because only a small percentage of all patients infected with HCV develop osteosclerosis (4), the pathogenesis and natural history of HCAO is unknown yet. Here we report a case of HCAO with xanthogranulomatous cholecystitis, in which serum alkaline phosphatase (ALP) and bone turnover markers were dramatically decreased after cholecystectomy.
Case Report
A 62-year-old woman presented with markedly increased serum ALP in October 2007. She was found to be HCV antibody positive in 1992 and ALP levels remained slightly elevated, but were essentially stable during regular follow-up of chronic hepatitis. As the abdominal CT scans demonstrated thickening of the gallbladder wall, gallbladder cancer was suspected. She was admitted to our hospital for further examination in December 2007. She had no subjective symptoms such as abdominal pain and bone pain. Her past medical history was negative for lung disease, blood transfusion, drug abuse and tattoos. A gallstone was noted in 1997 and regular follow-up showed no marked change. There was no family history of skeletal disease. On physical examination, she was found to be thin (height 165 cm, weight 47.6 kg, BMI 17.5). Her blood pressure was 108/64 mmHg and pulse rate was 76 beats/min. There were no remarkable findings on the chest and abdomen. She had no skeletal deformities and clubbed fingers. Dentition was normal and there were no auditory symptoms.
Laboratory data are shown in There was increased urinary NTX/Cr reflecting enhanced bone resorption, and an increased serum osteocalcin level reflecting enhanced bone formation. Initially, because bone-derived ALP was remarkably elevated, we suspected bone metastasis, including lung cancer and breast cancer; however, there was no evidence of lung cancer and breast cancer on chest radiography, mammography and tumor markers. Moreover, M-protein and Bence-Jones proteinuria, which have been known to increase in multiple myeloma, were negative. Total bone scintigraphy showed diffuse enhanced uptake of all major bones (Fig. 1 ). Bone mineral densities (BMD) of the lumbar spine and the femoral neck were above the mean peak bone mass of young women (BMD 1.284 g/cm 2 and T score +1.4SD, and BMD 1.162 g/cm 2 and T score +2.2SD, respectively), and +3.0SD and +4.1SD of mean values for age-matched female controls. These findings were consistent with hepatitis C-associated osteosclerosis (HCAO), a rare syndrome characterized by a marked increase of bone mass in adults infected with HCV.
Abdominal CT revealed gallbladder wall thickening and multiple gallstones in the gallbladder ( Fig. 2A) . F-18-fluorodeoxyglucose positron emission tomography (FDG-PET) demonstrated strong accumulation on the bottom of the gallbladder, but no other abnormal uptake could be found ( Fig. 2B and C) . As gallbladder cancer was suspected, she underwent a cholecystectomy in January 2008. The surgical specimen demonstrated numerous gallstones in the gallbladder and wall thickening around the bottom of the gallbladder. Histological examination unexpectedly revealed xanthogranulomatous cholecystitis (XGC) with no evidence of malignancy.
The postoperative course was completely uneventful. Her clinical course is shown in Fig. 3 . One week after surgery, the serum ALP level was suddenly decreased to 1556 IU/L; however, because the ALP level gradually increased subsequently, she was treated with oral alendronate 35 mg per week from March to May 2008. The serum ALP level decreased to 1890 IU/L and urinary NTX/Cr to 140 nmBCE/ mMCr in May 2008. Moreover, serum bone-specific ALP level was 86.9 U/L (normal range: 9.6-35.4) and tartrateresistant acid phosphatase 5b (TRACP 5b) reflecting enhanced bone resorption was 406 mU/dL (normal range: 120-420) in December 2008. Thereafter, the ALP level progressively declined and normalized in January 2010, and urinary NTX/Cr decreased to 59.9 nmBCE/mMCr. Two years after surgery, the patient was asymptomatic and in good health. Total bone scintigraphy showed diffusely progressive increase of radioisotope accumulation from December 2007 to July 2008. BMD of the lumbar spine and femoral neck gradually increased until June 2009; however, there was no increase in January 2010 (Table 3 ). Representative radiographs showed diffuse bone sclerosis with marked cortical thickening in June 2009 (Fig. 4) .
Discussion
HCAO is a rare disorder, characterized by a generalized increase in bone mass in adults infected with HCV (3). This condition was initially described in 1990 (5) and to date only sixteen cases of HCAO, including 3 cases in Japan (6-8), have been reported. Skeletal radiographs show generalized cortical thickening. Skeletal scintigraphy demonstrates diffusely increased uptake of radiolabeled agents, but does not show focal defects. Bone density gradually increased over a period of several years. Transiliac bone biopsy with tetracycline labeling showed not only an increased bone formation rate, but good quality with intact lamellar patterns of osseous tissue. Serum calcium and phosphorous were normal but urinary calcium excretion was decreased. Patients have markedly elevated serum levels of bone formation markers, such as bone-type ALP. Serum PTH level and 1,25-dihydroxyvitamin D level were increased or normal, presumably due to mild secondary hyperparathyroidism. Despite the marked increase in bone mass, patients do not demonstrate cranial nerve compressions, such as facial palsy, deafness, visual problems or marrow compromise. There are no reports of bone deformity or fracture. This disease is spontaneously limited to several years and the pain resolves.
Although the pathogenesis of HCAO is still unknown, systemic factors induced by the liver or other tissues affected by HCV infection may be responsible for the systemic bone lesions in this disease. Previous studies demonstrated abnormalities in the insulin-like growth factor (IGF) system (9), the soluble receptor activator of nuclear factorkappa B legend (RANKL) and osteoprotegerin (OPG) system imbalance (10, 11) and the participation of transforming growth factor (TGF)-β-Smad signaling (8) . It is well established that multiple soluble mediators, including cytokines, chemokines, and growth factors, regulate osteoblast and osteoclast activities (12) . Furthermore, mounting evidence suggests that the cytokine complex network is linked to the pathogenesis of hepatic and extra-hepatic manifestations, and treatment response rates among HCV-infected patients (13) . For instance, interleukin-2 (IL-2), interferon-γ (IFN-γ) and TGF-β are upregulated in chronic HCV-infected patients compared with uninfected controls, and the levels of these cytokines are correlated with histologic fibrosis (14) (15) (16) . These findings suggest that HCV infection may regulate osteoblast and osteoclast activity by altering the cy- tokine environment; however, only a small percentage of all patients infected with HCV develop osteosclerosis (4) . This presumably means that other factors in addition to HCV infection are necessary to develop osteosclerosis. The present patient had complicated XGC, and serum ALP level and bone turnover markers were decreased after cholecystectomy. This may indicate the existence of a novel osteogenic factor in the gallbladder in HCAO. In a past, there is one case report of HCAO with gallbladder disease. Although this patient underwent cholecystectomy for gallbladder stones, he had persistent bone pain (10) . Thus, the pathogenesis of HCAO may not be completely explained by only the factor Table 3 . Changes in Bone Densitometry from the gallbladder. In addition, we cannot completely exclude the possibility of other diseases such as Paget's disease of bone, because a bone biopsy was not performed.
XGC is found in approximately 1.46% of cholecystectomies (17) and is almost always in the presence of gallstones (91%-100%) (18) . It is thought that in the presence of gallstones, obstruction, and cholestasis, XGC results from the extravasation of bile into the gallbladder wall. There are no reports of relationship between HCV infection and XGC. With the involvement of Rokitansky-Aschoff sinuses, the process is supposed to start as an initial inflammatory process, followed by a granulomatous reaction (17) . Histologically, abundant so-called foam cells (histiocytes) are mixed with chronic and acute inflammatory cells (19) . Preoperative or intraoperative differential diagnosis of XGC from gallbladder carcinoma remains a challenge, especially in patients with extensive pseudotumoral involvement of the surrounding structures and organs (20) .
In summary, we encountered a case of HCAO with XGC. Serum ALP and bone turnover markers were markedly increased; however, serum calcium, phosphorus and intact-PTH levels were normal. BMD of the lumbar spine and femoral neck were above the mean peak bone mass of young women. Total bone scintigraphy showed diffuse enhanced uptake of all major bones. These findings were consistent with HCAO. In this patient, serum ALP level and bone turnover markers were decreased after cholecystectomy. This finding may indicate the existence of a novel osteogenic factor in the gallbladder in HCAO.
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